Redefining Tumor Vascular Permeability through Deep Learning-Guided Microneedle Delivery
Abstract
Low-permeability (LP) tumor vasculature constitutes a major barrier to efficient nanomedicine delivery, making quantitative assessment and mechanistic understanding of vascular permeability essential for the rational design of delivery strategies. Here, we introduce a deep learning-guided microneedle (MN) delivery platform that enables localized and spatiotemporally precise modulation of tumor vasculature to enhance nanoparticle extravasation. By integrating the MN system with an upgraded single-vessel analysis framework (nano-ISML 1.1), we quantitatively mapped vascular remodeling and nanoparticle transport across diverse tumor types and particle sizes. Localized histamine delivery via MNs selectively expanded endothelial junctions through VE-cadherin-mediated regulation, significantly increasing the frequency and length of interendothelial gaps, and thereby reprogramming LP tumors toward a high-permeability phenotype. This controlled vascular remodeling established a pronounced size-dependent permeability window, defined by locally induced gap dimensions that varied across tumor types, permitting efficient penetration of nanoparticles ≤200 nm while largely excluding particles >500 nm. By uniting nanotechnology, vascular biology, and artificial intelligence, this interdisciplinary framework provides a mechanistic and predictive paradigm for overcoming vascular barriers and advancing the rational design of tumor-targeted nanomedicines.
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Advancements in Transdermal Drug Delivery
Nanoparticle-Based Drug Delivery
Publication details
- Journal / source
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Volume
- 20
- Issue
- 7
- Pages
- 5613–5628
- Publication date
- 9 February 2026
- Language
- EN